Clinical management Flashcards
(116 cards)
How is GDM diagnosed?
75g OGTT with 2h glucose
Diagnose gestational diabetes if the woman has either:
- a fasting plasma glucose level of 5.6 mmol/litre or above or
- a 2‑hour plasma glucose level of 7.8 mmol/litre or above.
Who should be offered a OGTT?
Those with risk factors for GDM:
- BMI above 30 kg/m2
- previous macrosomic baby weighing 4.5 kg or more
- previous gestational diabetes
- family history of diabetes (first‑degree relative with diabetes)
- an ethnicity with a high prevalence of diabetes
- glycosuria of 2+ or more on 1 occasion or glycosuria of 1+ on 2 or more occasions
Testing at 24-28 weeks
If previous GDM, offer OGTT ASAP after booking and again at 24-28 weeks if normal.
Suture materials/ techniques for repairing anal mucosa/ IAS/ EAS
AM: continuous or interrupted, 3-0 polyglactin (Vicryl)
IAS: interrupted/ mattress. Monofilament e.g. 3-0 PDS, or 2-0 polyglactin (vicryl).
Sutures must not overlap, end to end only.
EAS: end to end monofilament e.g. 3-0 PDS or 2-0 polyglactin (vicryl)
Sutures can be overlapping or end-to end.
For partial thickness, end to end should be used.
Incidence of OASIS in UK
Prognosis
6.1% for primip
1.7% for multip
60-80% of women asymptomatic 12 months post delivery and EAS repair
Incidence of obstetric cholestasis in UK
OC monitoring
OC implications
0.7%
Itching in general affects 23% of pregnancies
Itching can occur before biochemical changes.
If LFTs normal, but itching continues LFTs should be repeated in 1-2 weeks & consider testing for other causes of itch
If LFTs deranged, should be monitored every 1-2 weeks throughout pregnancy and at least 10 days post natally
OC linked with increased incidence of passage of meconium, premature delivery, fetal distress, stillbirth, delivery by CS and PPH
Different criteria’s used to diagnose BV
Amsels criteria:
3/4 criteria required for confirmation of BV
1. Thin, white, homogeneous discharge
2. Clue cells on microscopy of wet mount
3. pH of vaginal fluid >4.5
4. Release of a fishy odour on adding alkali (10% KOH)
The Nugent score:
Estimates the relative proportions of bacterial morphotypes to give a score between 0 and 10
<4 = normal
4-6 = intermediate
>6 = BV
The Hay/Ison criteria:
- Grade 1 (Normal): Lactobacillus morphotypes predominate
- Grade 2 (Intermediate): Mixed flora with some Lactobacilli present, but Gardnerella or Mobiluncus morphotypes also present
- Grade 3 (BV): Predominantly Gardnerella and/or Mobiluncus morphotypes. Few or absent Lactobacilli
OSOM BVblue is a commercially available kit that BASHH advises performs adequately compared with Amsel criteria.
Detection of gardnella vaginalis on swab does not confirm BV, as bacteria can be present in up to 50% of women without BV
% of pregnant vs non-pregnant women asymptomatically colonised with candida
Pregnant 40%
Non-pregnant 20%
Uterotonics
Oxytocin:
- Nanopeptide primarily synthezised in the hypothalamus (supraoptic and paraventricular nuclei)
- The oxytocin receptor is a G-protein-coupled receptor requiring Mg2+ and cholesterol.
Prostaglandins
- Misoprostal (Synthetic Prostaglandin E1 analogue) half-life 40 minutes
- Dinoprostone (Naturally occurring Prostaglandin E2)
- Dinoprost (Naturally occurring Prostaglandin F2 Alpha)
- Carboprost (Synthetic Prostaglandin F2 Alpha analogue)
Ergometrine
- Ergot Alkaloid
- Stimulates 5HT2, dopamine and alpha adrenergic receptors but smooth muscle contraction mechanism of action not fully understood.
- Often used as combined preparation with Oxytocin (syntometrine)
- Should not be used in HTN
Medication regimes for medical abortion depending on gestation
All gestations, begin with Mifepristone 200mg PO
<7 weeks days:
24-48h later: 400mcg PO misoprostol
7-8 weeks:
24-48h later: 400mcg PO misoprostol + 2nd dose 400mcg PV or PO if no abortion 4h later
<9 weekss:
24-48h later: 800mcg misoprostol (PV/ buccal/ sublingual)
9-13 weeks:
36-48h later: 800mcg misoprostol PV. Up to 4 further doses of 400mcg misoprostol (PO/PV) at 3 hourly intervals
13-24 weeks:
- 36-48h later: 800mcg misoprostol PV. Up to 4 further doses of 400mcg misoprostol (PO/PV) at 3 hourly intervals.
- If abortion has not occurred, mifepristone can be repeated 3h after the last misoprostol followed by misoprostol 12 hours after that.
Who should be given anti-D in cases of abortion?
Rhesus Anti-D IgG should be given, by injection into the deltoid muscle, to women who are rhesus D negative and are having an abortion after 10+0 weeks’ gestation.
Anti-D prophylaxis should not be given to women who are having a medical abortion up to and including 10+0 weeks’ gestation.
Anti-D prophylaxis should be considered for women who are rhesus D negative and are having a surgical abortion up to and including 10+0 weeks’ gestation.
Prophylactic Abx regimes for surgical abortions
Doxycycline 100mg BD for 3 days
Metronidazole 1g PR or 800mg PO if tested negative for chlamydia
When to restart COCP following abortion/ miscarriage
Immediately
Risk factors for GDM
- Increasing age
- Certain ethnic groups (Asian, African Americans, Hispanic/Latino Americans and Pima Indians)
- High BMI before pregnancy (three-fold risk for obese women compared to non-obese women)
- Smoking doubles the risk of GDM
- Change in weight between pregnancies - an inter-pregnancy gain of more than three units (of BMI) doubles the risk of GDM
- Short interval between pregnancies
- Previous unexplained stillbirth
- Previous macrosomia
- Family history of type 2 diabetes or GDM - more relevant in nulliparous than parous women
Blood test monitoring on methotrexate
FBC/ U&E/ LTF every 1-2 weeks when initiating treatment.
Once established, every 2-3 months.
Risk of blood dyscradias (myelosuppression) and liver cirrhosis
Risk of complications with laparoscopy
Overall risk of ‘serious complications’ is 2/1000
Risk of bowel injury 0.4/1000
Risk of vascular injury 0.2/1000
Risk of death is 0.05 in 1000
Women must be informed of the risks and potential complications associated with laparoscopy. This should include discussion of the risks of the entry technique used: specifically, injury to the bowel, urinary tract and major blood vessels, and later complications associated with the entry ports: specifically, hernia formation.
No significant safety advantage to open (Hasson)/ closed entry techniques
Reduced risk of uterine injury in Hasson compared to verses
Management of sub fertility in WHO group I ovulation disorders
Group I: hypothalamic pituitary failure (stress, anorexia, exercise induced)
Increase BMI if <19
Reduce exercise if high levels
Pulsatile GnRH or gonadotropins with LH activity to induce ovulation
Management of sub fertility in WHO group II ovulation disorders
WHO group II: hypothalamic-pituitary-ovarian dysfunction
Weight reduction if BMI >30
Clomiphene (1st line)
Metformin (1st line)
Clomiphene & metformin (1st/2nd line)
Laparoscopic drilling (2nd line)
Gonadotrophins (2nd line)
Management of sub fertility in WHO group III ovulation disorders
Consider IVF with donor eggs
Management of hyperprolactinaemia
Investigate cause e.g. MRI head (?pituitary adenoma) medication review (some antipsychotic medications for example can cause prolactin rise)
Dopamine agonist (Bromocriptine advised by NICE as 1st line)
What should be given/ avoided in hyperemesis to reduce the risk of Wernicke’s encephalopathy?
Avoid dextrose: can exacerbate Wernickes.
Give IV pabrinex (10ml solution in 100ml saline)
Rotterdam criteria for diagnosing PCOS
Two of the three following criteria are diagnostic of the condition:
- Polycystic ovaries (either 12 or more peripheral follicles or increased ovarian volume (greater than 10 cm3)
- Oligo-ovulation or anovulation
- Clinical and/or biochemical signs of hyperandrogenism
Typical Biochemistry
- Elevated LH
- FSH normal or low
- LH:FSH >2 (normal is 1:1 ratio, PCOS is often 3:1)
- Testosterone, oestrogen, prolactin all typically normal or elevated
- SHBG normal or reduced
Associated Endocrine Disorders
- Diabetes
- Hypothyroidism
Recommendation regarding periods in PCOS
Oligo- or amenorrhoea in women with PCOS may predispose to endometrial hyperplasia and later carcinoma.
It is good practice to recommend treatment with gestogens to induce a withdrawal bleed at least every 3 to 4 months
Changes to reproductive system following delivery
Afterpains may continue for 2-3 days
Uterine involution takes 4-6 weeks
Lochia flow 3-6 weeks
Cervical constriction takes up to 7 days
Vaginal contraction and return of tone takes 4-6 weeks